| Literature DB >> 23349833 |
Hermine V Mkrtchyan1, Charlotte A Russell, Nan Wang, Ronald R Cutler.
Abstract
Antibiotic resistance in bacteria remains a major problem and environments that help to maintain such resistance, represent a significant problem to infection control in the community. Restrooms have always been regarded as potential sources of infectious diseases and we suggest they have the potential to sustain bacterial "resistomes". Recent studies have demonstrated the wide range of different bacterial phyla that can be found in non-healthcare restrooms. In our study we focused on the Staphylococci. These species are often skin contaminants on man and have been reported as common restroom isolates in recent molecular studies. We collected samples from 18 toilets sited in 4 different public buildings. Using MALDI-TOF-MS and other techniques, we identified a wide range of antibiotic resistant Staphylococci and other bacteria from our samples. We identified 19 different Staphylococcal species within our isolates and 37.8% of the isolates were drug resistant. We also identified different Staphylococcal species with the same antibiograms inhabiting the same restrooms. Bacterial "resistomes" are communities of bacteria often localised in specific areas and within these environments drug resistance determinants may be freely transferred. Our study shows that non-healthcare restrooms are a source of antibiotic resistant bacteria where a collection of antibiotic resistance genes in pathogenic and non-pathogenic bacteria could form a resistome containing a "nexus of genetic diversity"Entities:
Mesh:
Substances:
Year: 2013 PMID: 23349833 PMCID: PMC3547874 DOI: 10.1371/journal.pone.0054223
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of Family and Genera of bacteria identified by MALDI-TOF-MS.
| Family | Genus | No of isolates | |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| ||
|
|
| ||
Others include genera of Korucia (6); Rothia (2); Arthrobacter (2); Anaerococcus (3); Rhodococcus (2).
Concordance between conventional and direct and extracted MALDI-TOF-MS methods for Gram-negative isolates of three genera.
| Genera | Total | Conventional | D-MALDI-TOF | E-MALDI-TOF | AE increase(%) |
|
| 1 | 1 | 1 | 1 | n/a |
| Proteus | 5 | 5 | 1 | 4 | 80 |
| Acinetobacter | 7 | 7 | 1 | 6 | 85.7 |
D-MALDI-TOF (direct method); E-MALDI-TOF (extracted method); AE increase (increase of identification after alcoholic extraction).
Identification of Staphylococci isolates by MALDI-TOF MS and API ID 32 STAPH system compared with 16S RNA sequencing.
| MALDI-TOF MS | API ID 32 STAPH | PCR |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Profiles of resistant Gram-negative isolates found in restrooms.
| Gram-negative isolates | wr/B | Resistance Profiles β | |
|
| 1 K | Am, Co, KF, S, ST, TS | |
|
| 11 K | A, Co, G, GM, N,S, ST, T, Tb | |
|
| 12 K | Co, KF, ST, TS | |
|
| 18 K | Am, Am/S, GM, KF, S, ST, T,TS | |
|
| 18 K | Am, C, Ct, Cf, KF, S, ST, T,TS | |
wr/B* restroom/building code G,K,H or T.
β - A: Amikacin; Am: Ampicillin; Am/S: Ampicillin/Sulbactam; KF: Cephalotoxin; S: Streptomycin; ST: Sulphatriad; T: Tetracycline; TS: Cotrimoxazole; Co: Collstin Sulphate C: Cefepime; Ct: Cefotaxime; Cf: Ceftazidime; G: Gentamicin; Tb: tobramycin; N: Netilmicin.
Resistance profiles and molecular characterisation of antibiotic resistant Staphylococci isolated from 15 out of 18 different restrooms from 4 buildings (G,H,K,T).
| Species | Wr/B | n | A | Am | Az | C | Cl | Cp | Cx | E | F | Fa | G | I | L | Mc | Mp | Mx | N | P | S | St | T | Tb | O MIC | MecA |
|
| 1 K | 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | 2 | + | |||||||
|
| 2T | 1 | R | R | R | R | R | R | R | 0.25 | + | |||||||||||||||
|
| 4T | 1 | R | 64 | + | |||||||||||||||||||||
|
| 4T | 1 | R | R | R | R | R | R | R | R | R | R | 1 | + | ||||||||||||
|
| 4T | 1 | R | R | R | R | R | R | R | R | R | R | 0.75 | + | ||||||||||||
|
| 4T | 1 | R | R | R | R | R | R | R | R | R | R | R | 1 | + | |||||||||||
|
| 5T | 1 | R | R | R | R | R | R | R | R | R | R | 1 | + | ||||||||||||
|
| 6 K | 1 | R | R | R | R | R | R | R | 1.5 | + | |||||||||||||||
|
| 6 K | 1 | R | R | R | R | R | R | R | R | R | R | R | R | R | R | R | 2 | + | |||||||
|
| 7G | 1 | R | 0.5 | + | |||||||||||||||||||||
|
| 7G | 1 | R | R | R | R | R | R | R | 2 | + | |||||||||||||||
|
| 7G | 2 | R | R | R | R | R | R | R | F | R | R | R | R | 1 | + | ||||||||||
|
| 9H | 3 | R | R | R | R | R | R | R | 0.75–1.5 | + | |||||||||||||||
|
| 11 K | 1 | R | 64 | + | |||||||||||||||||||||
|
| 11 K | 1 | R | R | R | R | R | 0.75 | + | |||||||||||||||||
|
| 11 K | 1 | R | R | R | R | R | R | 0.75 | + | ||||||||||||||||
|
| 11 K | 1 | R | R | R | R | R | R | R | 1 | + | |||||||||||||||
|
| 12 K | 2 | R | R | R | R | 0.75 | + | ||||||||||||||||||
|
| 13H | 1 | R | 128 | + | |||||||||||||||||||||
|
| 13H | 1 | R | R | R | R | R | R | R | 1.5 | + | |||||||||||||||
|
| 14T | 2 | R | R | R | R | R | R | R | 0.5 | + | |||||||||||||||
|
| 15 K | 1 | R | R | R | 1 | + | |||||||||||||||||||
|
| 15 K | 1 | R | R | R | R | R | R | R | R | 4 | + | ||||||||||||||
|
| 16 K | 1 | R | R | R | R | R | R | 2 | + | ||||||||||||||||
|
| 16 K | 1 | R | R | R | R | R | R | R | 4 | + | |||||||||||||||
|
| 16 K | 2 | R | R | R | R | R | R | R | 0.5–1.5 | + | |||||||||||||||
|
| 16 K | 3 | R | R | R | R | R | R | R | 0.5–1.5 | + | |||||||||||||||
|
| 17 K | 1 | R | R | R | R | R | R | R | 64 | + | |||||||||||||||
|
| 18 K | 1 | R | 128 | + | |||||||||||||||||||||
|
| 18 K | 1 | R | R | R | R | 1 | + | ||||||||||||||||||
|
| 18 K | 1 | R | R | R | R | R | R | R | R | 4 | + |
n* similar isolates from each restroom but different sites.
wr/B* restroom/Building code G,K,H or T.
A: Amoxacillin; Am: Ampicillin; Az: Azitromycin; C: Cefepime; Cx: Cefuroxime:; Cp: ciprofloxacin; Cl: Clindamycin; E: Erythromycin; F: Fosfomycin; Fa: Fusidic Acid; G: Gentamicin; I: Imipenem; L: levofloxacin; Mp: Meropenem; Mx: Moxifloxacin; Mc: Mupiricin; N: Novobiocin; O: oxacillin; P: Penicillin; S: Streptomycin; T: Tetracycline. Tb: tobramycin.